QURE surges 20%
uniQure stock rises on Replimune FDA BLA news, potentially impacting gene therapy sector
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
uniQure stock rises on Replimune FDA BLA news, potentially impacting gene therapy sector
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.